SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on July 1, 2020. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report addresses corporate governance changes effective as of the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the appointment of Anthony Zook as a director of the Company, effective July 1, 2020. Mr. Zook will serve a term expiring at the next annual meeting of stockholders or until his successor is elected, or upon earlier death, resignation, or removal.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. The appointment was accompanied by a press release (Exhibit 99.1) incorporated by reference, but no unusual items or contingencies were disclosed in the text provided.
Investor Verification Checklist
- Verify the background and qualifications of the newly appointed director, Anthony Zook.
- Confirm the effective date of the appointment (July 1, 2020) against the company's official press release.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.
- Check for any subsequent filings regarding the composition of the Board of Directors.